Perrigo Company plc Other Operating Activities, Cash Flow Statement
Perrigo Company plc (PRGO) reported Other Operating Activities, Cash Flow Statement of -$8.70 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2026-08-05
- Perrigo Company plc other operating activities, cash flow statement for the quarter ending 2026-06-27 was -$5.50M.
- Perrigo Company plc other operating activities, cash flow statement for the quarter ending 2026-03-28 was -$3.20M, a 169.57% decline year-over-year.
- Perrigo Company plc other operating activities, cash flow statement for the quarter ending 2025-12-31 was $4.80M.
- Perrigo Company plc other operating activities, cash flow statement for the quarter ending 2025-09-27 was $800.00K.
- Perrigo Company plc other operating activities, cash flow statement for fiscal 2025 was $6.80M, a 1033.33% increase from fiscal 2024.
- Perrigo Company plc other operating activities, cash flow statement for fiscal 2024 was $600.00K, a 97.50% decline from fiscal 2023.
- Perrigo Company plc other operating activities, cash flow statement for fiscal 2023 was $24.00M, a 215.79% increase from fiscal 2022.
- Perrigo Company plc other operating activities, cash flow statement for fiscal 2022 was $7.60M, a 3700.00% increase from fiscal 2021.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 3 month as first filed | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 6 month as first filed | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 9 month as first filed | Other Operating Activities, Cash Flow Statement 12 month | Other Operating Activities, Cash Flow Statement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$8.70M 10-Q · filed 2026-08-05 | -$3.90M derived: sum of 3 quarters · filed 2026-08-05 | -$3.10M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | -$3.20M 10-Q · filed 2026-05-06 | $1.60M derived: sum of 2 quarters · filed 2026-05-06 | $2.40M derived: sum of 3 quarters · filed 2026-05-06 | -$1.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.60M derived: sum of 2 quarters · filed 2026-02-26 | $2.20M derived: sum of 3 quarters · filed 2026-08-05 | $6.80M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.60M derived: sum of 2 quarters · filed 2026-08-05 | $2.00M 10-Q · filed 2025-11-05 | -$7.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | -$3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.20M 10-Q · filed 2026-08-05 | -$9.00M 10-Q · filed 2025-08-06 | -$8.60M derived: sum of 3 quarters · filed 2026-08-05 | -$14.10M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-29 | $4.60M 10-Q · filed 2026-05-06 | -$4.80M 10-Q · filed 2025-05-07 | -$5.20M derived: sum of 2 quarters · filed 2026-05-06 | -$10.70M derived: sum of 3 quarters · filed 2026-05-06 | $12.60M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$15.30M derived: sum of 2 quarters · filed 2026-02-26 | $8.00M derived: sum of 3 quarters · filed 2026-02-26 | $600.00K 10-K · filed 2026-02-26 | -$9.50M 10-K · filed 2025-02-28 | |||
| 2024-09-28 | -$5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $17.80M derived: sum of 2 quarters · filed 2025-11-05 | $10.40M 10-Q · filed 2025-11-05 | $19.20M 10-Q · filed 2024-11-06 | $37.10M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-29 | $23.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $15.90M 10-Q · filed 2025-08-06 | $42.60M derived: sum of 3 quarters · filed 2026-02-26 | $38.30M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | -$7.40M 10-Q · filed 2025-05-07 | $19.30M derived: sum of 2 quarters · filed 2026-02-26 | $15.00M derived: sum of 3 quarters · filed 2026-02-26 | $10.20M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $26.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.40M derived: sum of 2 quarters · filed 2026-02-26 | $17.60M derived: sum of 3 quarters · filed 2026-02-26 | $24.00M 10-K · filed 2026-02-26 | $25.70M 10-K · filed 2024-02-27 | |||
| 2023-09-30 | -$4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$9.10M derived: sum of 2 quarters · filed 2024-11-06 | -$2.70M 10-Q · filed 2024-11-06 | $1.50M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.60M 10-Q · filed 2024-08-02 | $5.80M derived: sum of 3 quarters · filed 2025-02-28 | $14.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $6.40M 10-Q · filed 2024-05-07 | $10.60M derived: sum of 2 quarters · filed 2025-02-28 | $18.80M derived: sum of 3 quarters · filed 2025-02-28 | $31.50M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $12.40M derived: sum of 2 quarters · filed 2025-02-28 | $25.10M derived: sum of 3 quarters · filed 2025-02-28 | $7.60M 10-K · filed 2025-02-28 | $3.70M 10-K · filed 2023-02-28 | |||
| 2022-10-01 | $8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $20.90M derived: sum of 2 quarters · filed 2023-11-07 | $3.40M 10-Q · filed 2023-11-07 | -$5.60M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | $12.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.80M 10-Q · filed 2023-08-08 | -$13.80M derived: sum of 3 quarters · filed 2024-02-27 | -$23.40M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | -$17.50M 10-Q · filed 2023-05-09 | -$26.50M derived: sum of 2 quarters · filed 2024-02-27 | -$36.10M derived: sum of 3 quarters · filed 2024-02-27 | -$25.20M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$18.60M derived: sum of 2 quarters · filed 2024-02-27 | -$7.70M derived: sum of 3 quarters · filed 2024-02-27 | $200.00K 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | -$9.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.30M derived: sum of 2 quarters · filed 2022-11-08 | $9.20M 10-Q · filed 2022-11-08 | $35.20M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $18.80M 10-Q · filed 2022-08-09 | $44.80M derived: sum of 3 quarters · filed 2023-02-28 | $44.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $7.90M 10-Q · filed 2022-05-11 | $33.90M derived: sum of 2 quarters · filed 2023-02-28 | $33.40M derived: sum of 3 quarters · filed 2023-02-28 | $35.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $25.50M derived: sum of 2 quarters · filed 2023-02-28 | $28.00M derived: sum of 3 quarters · filed 2023-02-28 | $14.00M 10-K · filed 2023-02-28 | -$6.00M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.00M derived: sum of 2 quarters · filed 2021-11-12 | -$12.00M 10-Q · filed 2021-11-12 | -$12.70M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-27 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$11.50M 10-Q · filed 2021-08-11 | -$12.20M derived: sum of 3 quarters · filed 2022-03-01 | -$300.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-28 | -$14.00M 10-Q · filed 2021-05-12 | -$14.70M derived: sum of 2 quarters · filed 2022-03-01 | -$2.80M derived: sum of 3 quarters · filed 2022-03-01 | $10.20M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $11.20M derived: sum of 2 quarters · filed 2022-03-01 | $24.20M derived: sum of 3 quarters · filed 2022-03-01 | $37.60M 10-K · filed 2022-03-01 | $26.60M 10-K · filed 2020-02-27 | |||
| 2019-09-28 | $11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $24.90M derived: sum of 2 quarters · filed 2020-11-05 | $38.30M 10-Q · filed 2020-11-05 | $38.50M 10-Q · filed 2019-11-06 | $20.80M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-29 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $26.40M 10-Q · filed 2020-08-05 | $8.90M derived: sum of 3 quarters · filed 2021-03-01 | $10.20M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | $13.40M 10-Q · filed 2020-05-05 | -$4.10M derived: sum of 2 quarters · filed 2021-03-01 | -$2.80M derived: sum of 3 quarters · filed 2021-03-01 | -$9.80M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$16.20M derived: sum of 2 quarters · filed 2021-03-01 | -$23.20M derived: sum of 3 quarters · filed 2021-03-01 | -$11.10M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$5.70M derived: sum of 2 quarters · filed 2019-11-06 | $6.40M 10-Q · filed 2019-11-06 | $5.90M 10-Q · filed 2018-11-08 | $30.90M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $5.10M 10-Q · filed 2019-08-08 | $29.60M derived: sum of 3 quarters · filed 2020-02-27 | $23.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $12.10M 10-Q · filed 2019-05-09 | $36.60M derived: sum of 2 quarters · filed 2020-02-27 | $30.00M derived: sum of 3 quarters · filed 2020-02-27 | $10.50M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $24.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $17.90M derived: sum of 2 quarters · filed 2020-02-27 | -$1.60M derived: sum of 3 quarters · filed 2020-02-27 | -$2.70M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$26.10M derived: sum of 2 quarters · filed 2018-11-08 | -$27.20M 10-Q · filed 2018-11-08 | -$28.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | -$19.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$20.60M 10-Q · filed 2018-08-09 | -$21.60M derived: sum of 3 quarters · filed 2019-02-27 | -$15.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | -$1.10M 10-Q · filed 2018-05-08 | -$2.10M derived: sum of 2 quarters · filed 2019-02-27 | $4.30M derived: sum of 3 quarters · filed 2019-02-27 | $30.80M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $5.40M derived: sum of 2 quarters · filed 2019-02-27 | $31.90M derived: sum of 3 quarters · filed 2019-02-27 | $33.50M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | $6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $32.90M derived: sum of 2 quarters · filed 2017-11-09 | $34.50M 10-Q · filed 2017-11-09 | $49.40M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-07-02 | $26.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $28.10M 10-Q · filed 2017-08-10 | $28.20M 10-Q · filed 2016-08-10 | $43.00M derived: sum of 3 quarters · filed 2018-03-01 | $46.20M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-04-02 | $1.60M 10-Q · filed 2017-05-30 | $16.50M derived: sum of 2 quarters · filed 2018-03-01 | $19.70M derived: sum of 3 quarters · filed 2018-03-01 | $25.20M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $14.90M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $18.10M 10-K · filed 2018-03-01 | $17.50M 10-KT · filed 2016-02-25 | $23.60M derived: sum of 3 quarters · filed 2018-03-01 | $23.50M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $3.20M 10-Q · filed 2015-11-02 | $8.70M derived: sum of 2 quarters · filed 2017-05-22 | $8.40M 10-Q/A · filed 2017-05-23 | $15.30M 10-Q · filed 2016-11-10 | $16.90M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2015-06-27 | $5.50M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $5.40M 10-Q/A · filed 2017-05-22 | $12.10M 10-Q · filed 2016-08-10 | $13.70M derived: sum of 3 quarters · filed 2017-05-22 | $10.20M 10-K · filed 2018-03-01 | $17.00M 10-K · filed 2015-08-13 | ||
| 2015-03-28 | -$100.00K 10-Q/A · filed 2017-05-22 | -$200.00K 10-Q · filed 2016-05-16 | $8.20M derived: sum of 2 quarters · filed 2017-05-22 | $7.10M 10-Q · filed 2015-04-29 | $8.00M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-12-27 | $8.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $8.60M 10-Q · filed 2015-02-05 | $8.10M derived: sum of 3 quarters · filed 2017-05-22 | $6.80M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-09-27 | $300.00K 10-Q · filed 2015-11-02 | -$200.00K derived: sum of 2 quarters · filed 2017-05-22 | -$1.50M derived: sum of 3 quarters · filed 2017-05-22 | |||||
| 2014-06-28 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | -$1.80M derived: sum of 2 quarters · filed 2017-05-22 | $4.50M 10-K · filed 2017-05-22 | $10.50M 10-K · filed 2015-08-13 | ||||
| 2014-03-29 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $5.00M 10-Q · filed 2015-04-29 | ||||||
| 2013-12-28 | $6.30M 10-Q · filed 2015-02-05 | |||||||
| 2013-06-29 | -$3.40M 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |